FGF23 and chronic kidney disease: Moreover, the rise in serum FGF23 occurred in the complete absence of hyperphosphatemia in 5/6-Nx mice on either ND or CPD, further corroborating the notion that the early increase in FGF23 in CKD patients occurs independent of hyperphosphatemia and elevated PTH6.